地塞米松治疗预防一氧化碳中毒后迟发性神经精神后遗症:一项前瞻性登记研究
该研究为基于登记的前瞻性数据收集、回顾性分析,纳入2020年3月1日至2021年11月30日在一家韩国三级医院治疗的一氧化碳中毒患者128例,其中99例接受静脉地塞米松治疗、29例未接受。地塞米松组与非地塞米松组迟发性神经精神后遗症发生率分别为16.2%和37.9%。多因素logistic回归显示,地塞米松使用(OR=0.122,95%CI 0.031-0.489)和较高的格拉斯哥昏迷评分(OR=0.818,95%CI 0.682-0.981)与较低的迟发性神经精神后遗症发生率相关。作者结论认为早期地塞米松治疗与迟发性神经精神后遗症发生率降低显著相关。
要点
- 在128例一氧化碳中毒患者中,地塞米松组迟发性神经精神后遗症发生率为16.2%(99例中),非地塞米松组为37.9%(29例中)。
- 多因素logistic回归显示地塞米松使用与较低的迟发性神经精神后遗症发生率独立相关(OR=0.122,95%CI 0.031-0.489)。
- 较高的格拉斯哥昏迷评分亦与较低的迟发性神经精神后遗症发生率相关(OR=0.818,95%CI 0.682-0.981)。
- 该研究为登记数据前瞻性收集、回顾性分析,作者结论为早期地塞米松治疗与迟发性神经精神后遗症发生率降低显著相关。
适用人群与场景
- 2020年3月1日至2021年11月30日在一家韩国三级医院治疗的一氧化碳中毒患者,共128例,其中99例接受静脉地塞米松治疗、29例未接受。
处置流程与药物剂量
- 地塞米松经静脉给药;原文未写明具体剂量、频次和疗程。
研究设计与关键结果
- 研究类型为基于登记的前瞻性数据收集、回顾性分析,纳入128例一氧化碳中毒患者,其中地塞米松组99例、非地塞米松组29例。
- 地塞米松组迟发性神经精神后遗症发生率为16.2%,非地塞米松组为37.9%。
- 多因素logistic回归显示,地塞米松使用与较低的迟发性神经精神后遗症发生率相关(OR=0.122,95%CI 0.031-0.489)。
- 多因素logistic回归显示,较高的格拉斯哥昏迷评分与较低的迟发性神经精神后遗症发生率相关(OR=0.818,95%CI 0.682-0.981)。
证据类型、等级与局限
- 证据类型为基于登记的前瞻性数据收集、回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为早期地塞米松治疗与一氧化碳中毒后迟发性神经精神后遗症发生率降低显著相关,较高的格拉斯哥昏迷评分亦与较低发生率相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Delayed neuropsychiatric sequelae are major complications of carbon monoxide poisoning; carbon monoxide triggers brain oxidation and inflammation. Corticosteroids such as dexamethasone modulate neurological damage after carbon monoxide poisoning through anti-inflammatory actions and immune response inhibition. However, it is not known whether corticosteroids prevent delayed neuropsychiatric sequelae. We thus studied whether dexamethasone reduced the incidence of delayed neuropsychiatric sequelae.
METHODS: This registry-based study enrolled patients with carbon monoxide poisoning treated in a Korean tertiary care hospital from March 1st, 2020 to November 30th, 2021. Data of patients were prospectively collected during the study period, and retrospectively analyzed. One group received intravenous dexamethasone. We performed multivariable logistic regression analysis to identify factors associated with delayed neuropsychiatric sequelae.
RESULTS: A total of 128 patients were enrolled, of which 99 patients received dexamethasone therapy and 29 patients did not. The incidences of delayed neuropsychiatric sequelae in the dexamethasone and non-dexamethasone groups were 16.2% and 37.9%, respectively. Multivariable logistic regression analysis revealed that dexamethasone use (odds ratio = 0.122, 95% confidence interval 0.031-0.489) and a higher Glasgow Coma Scale (odds ratio = 0.818, 95% confidence interval 0.682-0.981) was associated with a lower incidence of delayed neuropsychiatric sequelae.
CONCLUSION: Early dexamethasone treatment was significantly associated with a decreased incidence of delayed neuropsychiatric sequelae. A higher Glasgow Coma Scale at presentation also was associated with a lower incidence of delayed neuropsychiatric sequelae.
参考来源
- Kim S, Choi S, Ko Y, et al. Dexamethasone therapy prevents delayed neuropsychiatric sequelae after carbon monoxide poisoning: a prospective registry-based study. Clin Toxicol (Phila). 2023. PMID: 36744989. doi:10.1080/15563650.2023.2169707
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。